Aug 30, 2023
Steve Kent is Chief Product Officer at Know Labs, which has developed a new sensor that uses noninvasive radiofrequency spectroscopy to measure molecules in the body. Their first target is to non-invasively measure glucose to help those with diabetes manage their conditions more effectively. As a sensor...
Aug 30, 2023
Steve Kent is Chief Product Officer at Know Labs, which has developed a new sensor that uses noninvasive radiofrequency spectroscopy to measure molecules in the body. Their first target is to non-invasively measure glucose to help those with diabetes manage their conditions more effectively. As a sensor...
Aug 25, 2022
Dr. Anthony Japour is the Chief Executive Officer and President at iTolerance, an early-stage privately-held regenerative medicine company. Currently, if a patient receives a pancreatic islet transplant to treat type 1 diabetes, there is a need for lifelong immune suppression. The technology that iTolerance is...
Aug 25, 2022
Dr. Anthony Japour is the Chief Executive Officer and President at iTolerance, an early-stage privately-held regenerative medicine company. Currently, if a patient receives a pancreatic islet transplant to treat type 1 diabetes, there is a need for lifelong immune suppression. The technology that iTolerance is...
Apr 25, 2022
Dr. John Bellettiere is the assistant professor of epidemiology at the Herbert Wertheim School of Public Health and Human Longevity Science at UC San Diego. Alexis Garduno is a third-year student in the UC San Diego and San Diego State University joint doctoral program in public health and the first author in a...